Adverse events after riboflavin/UV-A corneal cross-linking: a literature review
Abstract
Riboflavin/UV-A corneal cross-linking (CXL) for treating keratoconus and iatrogenic corneal ectasia has been well-established as first treatment option to stabilize corneal tissue biomechanical instability. Although the plethora of clinical studies has been published into the field, there is no systematic review assessing the type and frequency of adverse events after CXL.A systemic literature review on clinical safety and adverse events after...
Paper Details
Title
Adverse events after riboflavin/UV-A corneal cross-linking: a literature review
Published Date
Aug 27, 2021
Journal
Volume
42
Issue
1
Pages
337 - 348
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History